Modulate Therapeutics' Seed VC Round

Modulate Therapeutics raised a round of funding on February 01, 2016. Investors include TVM Capital Life Science.

Modulate Therapeutics plans to develop, to proof-of-concept, the compound IMM-01 that is designed to re-engage the immune system in order to recognize and eradicate neoplastic disease.…

Articles about Modulate Therapeutics' Seed VC Round: